Overview
Silver-Russell syndrome due to an imprinting defect of 11p15 (SRS) is a specific molecular subtype of Silver-Russell syndrome caused by epigenetic alterations at the imprinted region on chromosome 11p15.5. This region contains two imprinting control regions (ICR1 and ICR2) that regulate the expression of growth-related genes, including IGF2 and H19. In this subtype, loss of methylation (hypomethylation) at ICR1 on the paternal allele leads to reduced expression of IGF2, a key growth factor, resulting in significant prenatal and postnatal growth restriction. This molecular mechanism accounts for approximately 30-60% of all Silver-Russell syndrome cases. The condition is characterized by severe intrauterine growth restriction (IUGR), low birth weight and length, postnatal growth failure with relative macrocephaly, a triangular face with a prominent forehead and small pointed chin, body asymmetry (limb length discrepancy), feeding difficulties in early childhood, and fifth finger clinodactyly. Affected children often have poor appetite, low body mass index, and may experience hypoglycemia due to limited fat stores and feeding problems. Cognitive development is generally normal, though some children may experience mild learning difficulties or speech delay. Management of Silver-Russell syndrome due to 11p15 imprinting defects is multidisciplinary. Growth hormone therapy is a well-established treatment that can improve final adult height and body composition, and is typically initiated in early childhood. Nutritional support is critical, particularly in infancy and early childhood, to prevent hypoglycemia and ensure adequate caloric intake. Monitoring for premature adrenarche and early or precocious puberty is recommended, as these may further compromise final height. Orthopedic evaluation may be needed for significant limb length discrepancy. Long-term follow-up includes monitoring for metabolic complications and psychosocial support.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Silver-Russell syndrome due to an imprinting defect of 11p15.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Silver-Russell syndrome due to an imprinting defect of 11p15 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Silver-Russell syndrome due to an imprinting defect of 11p15.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Silver-Russell syndrome due to an imprinting defect of 11p15.
Community
No community posts yet. Be the first to share your experience with Silver-Russell syndrome due to an imprinting defect of 11p15.
Start the conversation →Latest news about Silver-Russell syndrome due to an imprinting defect of 11p15
No recent news articles for Silver-Russell syndrome due to an imprinting defect of 11p15.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Silver-Russell syndrome due to an imprinting defect of 11p15
What is Silver-Russell syndrome due to an imprinting defect of 11p15?
Silver-Russell syndrome due to an imprinting defect of 11p15 (SRS) is a specific molecular subtype of Silver-Russell syndrome caused by epigenetic alterations at the imprinted region on chromosome 11p15.5. This region contains two imprinting control regions (ICR1 and ICR2) that regulate the expression of growth-related genes, including IGF2 and H19. In this subtype, loss of methylation (hypomethylation) at ICR1 on the paternal allele leads to reduced expression of IGF2, a key growth factor, resulting in significant prenatal and postnatal growth restriction. This molecular mechanism accounts fo
How is Silver-Russell syndrome due to an imprinting defect of 11p15 inherited?
Silver-Russell syndrome due to an imprinting defect of 11p15 follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Silver-Russell syndrome due to an imprinting defect of 11p15 typically begin?
Typical onset of Silver-Russell syndrome due to an imprinting defect of 11p15 is neonatal. Age of onset can vary across affected individuals.